ACRV · Forms 3, 4, 5
Insider trades at Acrivon Therapeutics, Inc.
1 insider sold $585 of Acrivon Therapeutics, Inc. stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Acrivon Therapeutics, Inc. (ACRV) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mary Miller | Chief Legal Officer | Sell | 294 | $1.99 | $585 | Form 4 | |
| Michaela Levin | Chief Business Officer | Became an insider (Form 3) | Form 3 | ||||
| Michaela Levin | Chief Business Officer | Award | 30,000 | Form 4 | |||
| Peter Blume-Jensen | President and CEO | Sell | 14,036 | $2.21 | $31K | Form 4 | |
| Katharine Peterson | Chief Accounting Officer | Sell | 101 | $2.01 | $203 | Form 4 | |
| Mary Miller | Chief Legal Officer | Sell | 185 | $2.01 | $372 | Form 4 | |
| Erick Gamelin | Chief Development Officer | Sell | 400 | $2.01 | $804 | Form 4 | |
| Eric Devroe | Chief Operating Officer | Sell | 604 | $2.01 | $1K | Form 4 | |
| Peter Blume-Jensen | President and CEO | Sell | 1,229 | $2.01 | $2K | Form 4 | |
| Peter Blume-Jensen | President and CEO | Sell | 484 | $2.01 | $973 | Form 4 | |
| Adam D. Levy | Chief Financial Officer | Sell | 1,142 | $1.57 | $2K | Form 4 | |
| Mary Miller | Chief Legal Officer | Sell | 573 | $1.76 | $1K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.